You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematologic

Showing 1 - 25 of 6,035
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relmacabtagene Autoleucel in Hematologic Malignancies

Not yet recruiting
  • Lymphoma, B-Cell
  • +2 more
  • Relmacabtagene Autoleucel
  • Beijing, Beijing, China
  • +1 more
Nov 15, 2023

Hematologic Malignancy Trial (Cold-stored platelet concentrate)

Not yet recruiting
  • Hematologic Malignancy
  • Cold-stored platelet concentrate
  • (no location specified)
Apr 14, 2023

Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

Not yet recruiting
  • Hematologic Malignancy
  • +2 more
  • Flow Cytometry
  • Nanjing, Jiangsu, China
  • +2 more
Apr 17, 2023

Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

Recruiting
  • Hematologic Malignancies
  • RD13-02 cell infusion
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jun 26, 2023

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Hematologic Malignancy Trial in Tianjin (IMM01)

Terminated
  • Hematologic Malignancy
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023

Hematologic Diseases Trial in Hefei (allogeneic ?9d2 T Cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Hematologic Diseases
  • allogeneic γ9δ2 T Cells
  • +3 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Feb 23, 2023

Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Sep 5, 2023

SARS-CoV-2 Infection in Hematologic Tumors

Active, not recruiting
  • SARS-CoV-2 Infection
  • Hematologic Malignancy
  • None intervention
  • Beijing, Beijing, China
    Peking University First Hospital
Jan 13, 2023

Hematologic Diseases, Tumors Trial in Hangzhou (CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation)

Recruiting
  • Hematologic Diseases
  • Neoplasms
  • CD7 CAR-T cells injection
  • Allogeneic hematopoietic stem cell transplantation
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Apr 11, 2023

Cognitive Impairment, Hematologic Malignancy Trial in Birmingham (Modified ketogenic diet using an exogenous ketogenic formula,

Recruiting
  • Cognitive Impairment
  • Hematologic Malignancy
  • Modified ketogenic diet using an exogenous ketogenic formula
  • Online cognitive training
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 31, 2023

Hematologic Diseases Trial in Haifa (Naturopathic-pharmacological consultation)

Recruiting
  • Hematologic Diseases
  • Naturopathic-pharmacological consultation
  • Haifa, Israel
    Bnai Zion Medical Center
Jul 30, 2023

19 and 22+ B Cell Hematologic Tumors Trial in Wuhan (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

Recruiting
  • 19 and 22+ B Cell Hematologic Tumors
  • 19 and 20+ B Cell Hematologic Tumors
  • Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells
  • Wuhan, Hubei, China
    Tongji Hospital
Jan 11, 2023

Prospective Validation of the OHI Index

Recruiting
  • HLH
  • +4 more
    • Kfar Saba, Israel
    • +1 more
    May 21, 2023

    Thoracic Scanographic Characteristics of Hematologic Malignancy

    Recruiting
    • Mediastinal Diseases
    • analysis of thoracic scans
    • Toulouse, France
      Muriel Picard
    Jan 12, 2023

    Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

    Not yet recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • +5 more
    • Routine care as per site standard.
    • (no location specified)
    Sep 15, 2023

    Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +2 more
    • RD13-02 cell infusion
    • Hefei, Anhui, China
      The First Affiliated Hospital of University of Science and Techn
    Jun 5, 2023

    Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

    Recruiting
    • Hematologic Malignancy
    • +4 more
    • Palliative Care
    • Usual Care
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 24, 2023

    Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • CC312
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 12, 2023

    Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

    Recruiting
    • Hematological Malignancy
    • Cancer-Related Anemia
    • Shengxuening Tablet
    • Ferrous succinate
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Mar 13, 2023

    Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)

    Not yet recruiting
    • Hematologic Neoplasms
    • +5 more
    • umbilical cord derived mesenchymal stem cells
    • Wuhan, Hubei, China
    • +2 more
    Jan 3, 2023

    Hematologic Tumors Trial in Nanjing (virtual reality device)

    Recruiting
    • Hematologic Neoplasms
    • virtual reality device
    • Nanjing, Jiangsu, China
      the First Affiliated Hospital of Nanjing Medical University
    Oct 28, 2022

    Hematologic Cancer Trial (anxiety questionnaire)

    Not yet recruiting
    • Hematologic Cancer
    • anxiety questionnaire
    • (no location specified)
    Jul 11, 2023

    Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +2 more
    • RD13-02 cell infusion
    • Xuzhou, Jiangsu, China
      Affiliated hospital of Xuzhou medical college
    Jun 7, 2023

    Hematologic Malignancy Trial in Zhejiang (IBI322)

    Recruiting
    • Hematologic Malignancy
    • IBI322
    • Zhejiang, China
      The Second Affiliated Hospital Zhejiang University School of Med
    Sep 12, 2022